Canada markets open in 6 hours 42 minutes

Canopus BioPharma Incorporated (CBIA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.04700.0000 (0.00%)
At close: 10:55AM EDT

Canopus BioPharma Incorporated

233 Wilshire Boulevard
Suite 700
Santa Monica, CA 90401
United States
353-627-8674

Sector(s)Financial Services
IndustryShell Companies
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Patrick T. PrendergastChairman & CEON/AN/AN/A
Mr. Leo J. PrendergastCOO & DirectorN/AN/AN/A
Mr. Andries J. Lategan B.Pharm, M.Sc, Ph.D.Chief Scientific OfficerN/AN/AN/A
Ms. Elizabeth Shanahan B.Sc. (Hon)Pres of Oncology DivisionN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.

Corporate Governance

Canopus BioPharma Incorporated’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.